Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling

No abstract is available for this paper.

• Publication year

  2011

• Venue

  The FASEB Journal

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1096/fj.10-177816PMID 21507898PMCID PMC3136343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.

  2011cited by this paper
• Phosphaturic action of fibroblast growth factor 23 in Npt2 null mice.

  2010cited by this paper
• Expression and distribution of SIBLING proteins in the predentin/dentin and mandible of hyp mice.

  2010cited by this paper
• Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1α,25‐dihydroxyvitamin D3 synthesis in leptin‐deficient ob/ob Mice

  2010cited by this paper
• Nuclear Isoforms of Fibroblast Growth Factor 2 Are Novel Inducers of Hypophosphatemia via Modulation of FGF23 and KLOTHO*

  2009cited by this paper
• Regulation of Fibroblast Growth Factor 23 Production in Bone in Uremic Rats

  2009cited by this paper
• Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator.

  2009cited by this paper
• Novel regulators of Fgf23 expression and mineralization in Hyp bone.

  2009cited by this paper
• Bone formation regulates circulating concentrations of fibroblast growth factor 23.

  2009cited by this paper
• Fibroblast growth factor receptor-1 (FGFR1) nuclear dynamics reveal a novel mechanism in transcription control.

  2009cited by this paper
• Direct Binding of Integrin αvβ3 to FGF1 Plays a Role in FGF1 Signaling*

  2008cited by this paper
• Studies of the DMP1 57-kDa Functional Domain both in vivo and in vitro

  2008cited by this paper
• Pathogenic role of Fgf23 in Dmp1-null mice.

  2008influential reference
• Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.

  2008cited by this paper
• A translocation causing increased α-Klotho level results in hypophosphatemic rickets and hyperparathyroidism

  2008cited by this paper
• Impaired Energetic Metabolism After Central Leptin Signaling Leads to Massive Appendicular Bone Loss in Hindlimb‐Suspended Rats

  2008cited by this paper
• Endocrine functions of bone in mineral metabolism regulation.

  2008influential reference
• betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.

  2008cited by this paper
• Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.

  2007cited by this paper
• Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.

  2007cited by this paper
• Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.

  2007cited by this paper
• Klotho converts canonical FGF receptor into a specific receptor for FGF23

  2006cited by this paper
• Regulation of Fibroblast Growth Factor-23 Signaling by Klotho*

  2006cited by this paper
• Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

  2006influential reference
• Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism

  2006influential reference
• Pathogenic role of Fgf23 in Hyp mice.

  2006influential reference
• Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin.

  2006cited by this paper
• Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men.

  2006cited by this paper
• Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice.

  2005cited by this paper
• Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors.

  2005cited by this paper
• Parathyroid hormone - a bone anabolic and catabolic agent.

  2005cited by this paper
• 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.

  2005cited by this paper
• Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone.

  2005cited by this paper
• Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation.

  2005cited by this paper
• Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia.

  2005cited by this paper
• Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

  2005cited by this paper
• Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.

  2005cited by this paper
• FGF23 is processed by proprotein convertases but not by PHEX.

  2004cited by this paper
• Evolution of the Fgf and Fgfr gene families.

  2004cited by this paper
• Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.

  2004cited by this paper
• Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.

  2004cited by this paper
• Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism.

  2004cited by this paper
• bFGF Administration Lowers the Phosphate Threshold for Mineralization in Bone Marrow Stromal Cells

  2003cited by this paper
• Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX*

  2003cited by this paper
• The Dentin Matrix Protein 1 (Dmp1) is Specifically Expressed in Mineralized, but not Soft, Tissues during Development

  2003cited by this paper
• Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression

  2002cited by this paper
• Thyroid hormone activates fibroblast growth factor receptor-1 in bone.

  2002cited by this paper
• Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis

  2001cited by this paper
• Analysis of recombinant Phex: an endopeptidase in search of a substrate.

  2001cited by this paper
• Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

  2001cited by this paper
• FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.

  2001cited by this paper
• Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain.

  2000cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Bone Anabolic Effects of Basic Fibroblast Growth Factor

  1999cited by this paper
• Intrinsic mineralization defect in Hyp mouse osteoblasts.

  1998cited by this paper
• Cloning and Sequencing of Human PEX from a Bone cDNA Library: Evidence for Its Developmental Stage‐Specific Regulation in Osteoblasts

  1997cited by this paper
• Growth factors in the extracellular matrix

  1997cited by this paper
• Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.

  1997cited by this paper
• A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets

  1995cited by this paper
• Additivity of mutational effects in proteins.

  1990influential reference

• DMP1-Mediated FAK Activation Contributes to P Utilization of Broiler Osteoblasts by Suppressing FGF23 Expression

  2026cites this paper
• Current advances of bone homeostasis imbalance in the cause of hereditary metabolic bone diseases

  2026cites this paper
• Chorein Regulates Key Osteoblast Genes in UMR-106 Cells.

  2025cites this paper
• High fat diet induces gastric production of fibroblast growth factor 23 (FGF23)

  2025cites this paper
• 3D Osteocyte Networks under Pulsatile Unidirectional Fluid Flow Stimuli (PUFFS)

  2025cites this paper
• Connecting Bone Remodeling and Regeneration: Unraveling Hormones and Signaling Pathways

  2025cites this paper
• Blood vessel and osteocyte networks concurrently rearrange during bone maturation and decline during aging in the femur of male mice

  2025cites this paper
• Sclerostin and Wnt Signaling in Idiopathic Juvenile Osteoporosis Using High-Resolution Confocal Microscopy for Three-Dimensional Analyses

  2024cites this paper
• Emerging concepts on the FGF23 regulation and activity

  2024cites this paper
• Effect of Mutation Type on Ectopic Ossification Among Adult Patients With X-Linked Hypophosphatemia

  2024cites this paper
• Reduced estrogen signaling contributes to bone loss and cardiac dysfunction in interleukin‐10 knockout mice

  2024influential citation
• Pleiotropic effects of a recessive COL1α2 mutation occurring in a mouse model of severe osteogenesis imperfecta

  2024cites this paper
• Complex intrinsic abnormalities in osteoblast lineage cells of X-linked hypophosphatemia: Analysis of human iPS cell models generated by CRISPR/Cas9-mediated gene ablation.

  2024cites this paper
• FGF23 directly inhibits osteoprogenitor differentiation in Dmp1-knockout mice

  2023influential citation
• Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH)

  2023cites this paper
• An overview of fibroblast growth factor 23 and its role in kidney function

  2023cites this paper
• Klotho overexpression is frequently associated with upstream rearrangements in fusion-negative phosphaturic mesenchymal tumors of bone and sinonasal tract.

  2023cites this paper
• Pathogenic mechanisms of glucocorticoid-induced osteoporosis.

  2023cites this paper
• Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy

  2023cites this paper
• Mechanical loading modulates phosphate related genes in rat bone

  2023cites this paper
• Wnt pathway inhibitors are upregulated in XLH dental pulp cells in response to odontogenic differentiation

  2023cites this paper
• The pathophysiology of hypophosphatemia.

  2023cites this paper
• Generation of bicistronic Dmp1-Cre knock-in mice using a self-cleaving 2A peptide

  2023cites this paper
• All the Might of the Osteocyte: Emerging Roles in Chronic Kidney Disease.

  2023cites this paper
• Fgfr1 deficiency in osteocytes leads to increased bone mass by enhancing Wnt/β-catenin signaling.

  2023cites this paper
• Tumor-induced osteomalacia.

  2023cites this paper
• Single-cell RNA sequencing identifies Fgf23-expressing osteocytes in response to 1,25-dihydroxyvitamin D3 treatment

  2023cites this paper
• Tumor-induced osteomalacia: An overview.

  2023cites this paper
• Roles of osteocytes in phosphate metabolism

  2022influential citation
• Paracrine and endocrine functions of osteocytes

  2022cites this paper
• Novel Small Molecule Fibroblast Growth Factor 23 Inhibitors Increase Serum Phosphate and Improve Skeletal Abnormalities in Hyp Mice

  2022cites this paper
• Effects of tocotrienol on osteocyte-mediated phosphate metabolism in high-carbohydrate high-fat diet-induced osteoporotic rats

  2022cites this paper
• Advances in understanding of phosphate homeostasis and related disorders.

  2022cites this paper
• Pathogenesis of FGF23-Related Hypophosphatemic Diseases Including X-linked Hypophosphatemia

  2022cites this paper
• Growth-related skeletal changes and alterations in phosphate metabolism.

  2022cites this paper
• Novel Small Molecule Fibroblast Growth Factor 23 Inhibitors Increase Serum Phosphate and Improve Skeletal Abnormalities in Hyp Mice S

  2022cites this paper
• Shedding Light on the Complex Regulation of FGF23

  2022cites this paper
• Potential influences on optimizing long-term musculoskeletal health in children and adolescents with X-linked hypophosphatemia (XLH)

  2022cites this paper
• The Effects of Inorganic Phosphorus Levels on Phosphorus Utilization, Local Bone-Derived Regulators, and BMP/MAPK Pathway in Primary Cultured Osteoblasts of Broiler Chicks

  2022cites this paper
• TUMOR-INDUCED OSTEOMALACIA: A COMPREHENSIVE REVIEW.

  2022cites this paper
• Calcium-dependent activation of PHEX, MEPE and DMP1 in osteocytes

  2022cites this paper
• Fibroblast Growth Factor23 as a Novel Marker of Renal Impairment in Multiple Myeloma

  2022influential citation
• Endocrine Fibroblast Growth Factors in Relation to Stress Signaling

  2022cites this paper
• Dentin Matrix Protein 1 Silencing Inhibits Phosphorus Utilization in Primary Cultured Tibial Osteoblasts of Broiler Chicks

  2022cites this paper
• Osteocytes and the pathogenesis of hypophosphatemic rickets

  2022cites this paper
• Differentiation of osteoblasts: the links between essential transcription factors

  2022cites this paper
• Approach to Hypophosphatemic Rickets

  2022cites this paper
• Ultra-processed food targets bone quality via endochondral ossification

  2021cites this paper
• Genetic Disorders of Bone or Osteodystrophies of Jaws—A Review

  2021cites this paper
• FGF23 and bone disease

  2021cites this paper
• Vitamin A and Bone Health: A Review on Current Evidence

  2021cites this paper
• The Role of DMP1 in CKD-MBD

  2021cites this paper
• Osteocytes

  2021cites this paper
• Skeletal FGFR1 signaling is necessary for regulation of serum phosphate level by FGF23 and normal life span

  2021cites this paper
• Regulation of bone phosphorus retention and bone development possibly by related hormones and local bone-derived regulators in broiler chicks

  2021cites this paper
• Osteoblast biology: developmental origin and interactive nature of osteoblasts

  2021cites this paper
• FAM20C Overview: Classic and Novel Targets, Pathogenic Variants and Raine Syndrome Phenotypes

  2021cites this paper
• Impact of FasL Stimulation on Sclerostin Expression and Osteogenic Profile in IDG-SW3 Osteocytes

  2021cites this paper
• Familial hypophosphatemic rickets caused by a PHEX gene mutation accompanied by a NPR2 missense mutation

  2020cites this paper
• Can we enhance osteoporotic metaphyseal fracture healing through enhancing ultrastructural and functional changes of osteocytes in cortical bone with low‐magnitude high‐frequency vibration?

  2020cites this paper
• Fibroblast growth factor (FGF) and FGF receptor families in bone

  2020cites this paper
• Intrafibrillar Mineralized Collagen-Hydroxyapatite-Based Scaffolds for Bone Regeneration.

  2020cites this paper
• Disrupted Protein Expression and Altered Proteolytic Events in Hypophosphatemic Dentin Can Be Rescued by Dentin Matrix Protein 1

  2020influential citation
• What Can We Learn from FGF-2 Isoform-Specific Mouse Mutants? Differential Insights into FGF-2 Physiology In Vivo

  2020cites this paper
• Clinical Characteristics and Bone Features of Autosomal Recessive Hypophosphatemic Rickets Type 1 in Three Chinese Families: Report of Five Chinese Cases and Review of the Literature

  2020cites this paper
• Genetic pathways disrupted by ENPP1 deficiency provide insight into mechanisms of osteoporosis, osteomalacia, and paradoxical mineralization.

  2020cites this paper
• Small molecule FGF23 inhibitors increase serum phosphate and improve skeletal abnormalities in Hyp mice

  2020cites this paper
• Osteocytic FGF23 and Its Kidney Function

  2020cites this paper
• Simultaneous management of disordered phosphate and iron homeostasis to correct fibroblast growth factor 23 and associated outcomes in chronic kidney disease.

  2020cites this paper
• Cellular Contributors to Bone Homeostasis

  2020cites this paper
• Novel variants and uncommon cases among southern Chinese children with X-linked hypophosphatemia

  2020cites this paper
• Transcriptomics: a Solution for Renal Osteodystrophy?

  2020cites this paper
• FGF23: Is It Another Biomarker for Phosphate–Calcium Metabolism?

  2020cites this paper
• Clinical Characteristics and Bone Features of Autosomal Recessive Hypophosphatemic Rickets Type 1 in Three Chinese Families: Report of Five Chinese Cases and Review of the Literature

  2020cites this paper
• Fibroblast growth factors signaling in bone metastasis

  2020cites this paper
• Preparation and Characterization of Collagen-Hydroxyapatite-Based Composites for Biomedical Applications

  2019cites this paper
• Phosphorus Retention and Elevated FGF-23 in Chronic Kidney Disease

  2019cites this paper
• Journal of Bone and Mineral Research

  2019cites this paper
• Fibroblast growth factors in skeletal development.

  2019cites this paper
• Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications

  2019cites this paper
• Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders

  2019cites this paper
• Dynamics of serum phosphorus, calcium, and hormones during egg laying cycle in Hy‐Line Brown laying hens

  2019cites this paper
• Fibroblast Growth Factor 23 and Klotho in AKI.

  2019cites this paper
• Roles of Phosphate in Skeleton

  2019cites this paper
• How do we sense phosphate to regulate serum phosphate level?

  2019cites this paper
• Effects of different training modalities on phosphate homeostasis and local vitamin D metabolism in rat bone

  2019influential citation
• Mechanisms of phosphate transport

  2019cites this paper
• Regulation of fibroblast growth factor 23 (FGF23) in health and disease

  2019cites this paper
• Bone and heart health in chronic kidney disease: role of dentin matrix protein 1

  2019cites this paper
• DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease

  2019cites this paper
• 'Isolated' germline mosaicism in the phenotypically normal father of a girl with X-linked hypophosphatemic rickets.

  2019cites this paper
• Interplay Between FGF23, Phosphate, and Molecules Involved in Phosphate Sensing

  2019cites this paper
• Skeletal mineralization: mechanisms and diseases

  2019cites this paper
• PKC regulates the production of fibroblast growth factor 23 (FGF23)

  2019cites this paper
• Étude in vitro de la toxicité de l’uranium sur les cellules osseuses en vue de la recherche de nouveaux agents décorporants

  2018cites this paper
• Bone repair potential of human amniotic fluid stem cells

  2018cites this paper
• Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

  2018cites this paper
• X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.

  2018cites this paper
• Interactions Between Muscle and Bone

  2018cites this paper
• Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia: A 6-Year Prospective Cohort Study

  2018cites this paper